The move has triggered a $75m milestone payment to Vir as part of its 2024 exclusive global licence agreement with Sanofi.

Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sarepta ...

Vir Biotechnology has a strong cash position and is poised to generate definitive data in antivirals and oncology, making ...

RED BANK, NJ / ACCESS Newswire / July 23, 2025 / Tharimmune, Inc. (the “Company” and “Tharimmune”) (Nasdaq Capital ...

Biotechnology and biomedical engineering are distinct yet impactful fields shaping healthcare's future. Biotechnology delves ...

In a major step toward securing global food supplies and advancing sustainable agriculture, a team of scientists has proposed ...

Announcing the investment, Science, Innovation and Technology Minister Dr Shane Reti said the funding would support seven ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

While Silicon Valley profits off the AI boom, VC funding in the Bay State has plummeted. What's going on, and how can we fix ...

Learn what biotechnology is with simple explanations and fascinating examples! Discover hands-on science project ideas for students to explore biotech.

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their ...